Scholarlink

Background <p>In response to increasing opioid overdose, US providers reduced opioid prescribing, resulting in several unintended consequences.</p> Methods <p>We assessed the impact of opioid receipt on quality health indicators (QHI) among 300 adults prescribed opioids ≥ 3&#xa0;months in the past year for chronic non-cancer pain (CNCP), with a history of nonprescribed opioid or stimulant use. Achievement of 15 QHI was assessed: syphilis and tuberculosis screening; hepatitis A and B, influenza, and pneumococcal vaccinations; lipid panel; breast, cervical, and colon cancer screening; pneumocystis pneumonia prophylaxis; HIV care visit, viral load, CD4, and risk reduction counseling. We compared quarterly QHI achieved by opioid receipt separately, by category, and by HIV status using generalized estimating equations accounting for repeated measures within individuals.</p> Results <p>Opioid receipt was associated with achieving a higher proportion of recommended QHI (69.49% vs 63.34%; adjusted difference = +4.74%; 95% CI +3.15%, +6.34%) compared to no opioid receipt. Female versus male gender was associated with a lower proportion of QHI achieved (62.32% vs 69.33%; adjusted difference = −7.01%; 95% CI −11.20%, −2.83%). There was no difference by HIV status.</p> Conclusions <p>Patients losing access to opioids may receive less recommended preventive health care. Maintaining engagement in preventive and other healthcare should be a central component of opioid stewardship.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Receipt of prescribed opioids is associated with achieving quality healthcare indicators among patients with chronic non-cancer pain

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月16日

查看全文
  • Kyna Long,
  • Vanessa M. McMahan,
  • Starley B. Shade,
  • Irene Liu,
  • Glenn-Milo Santos,
  • Phillip O. Coffin

摘要

Background

In response to increasing opioid overdose, US providers reduced opioid prescribing, resulting in several unintended consequences.

Methods

We assessed the impact of opioid receipt on quality health indicators (QHI) among 300 adults prescribed opioids ≥ 3 months in the past year for chronic non-cancer pain (CNCP), with a history of nonprescribed opioid or stimulant use. Achievement of 15 QHI was assessed: syphilis and tuberculosis screening; hepatitis A and B, influenza, and pneumococcal vaccinations; lipid panel; breast, cervical, and colon cancer screening; pneumocystis pneumonia prophylaxis; HIV care visit, viral load, CD4, and risk reduction counseling. We compared quarterly QHI achieved by opioid receipt separately, by category, and by HIV status using generalized estimating equations accounting for repeated measures within individuals.

Results

Opioid receipt was associated with achieving a higher proportion of recommended QHI (69.49% vs 63.34%; adjusted difference = +4.74%; 95% CI +3.15%, +6.34%) compared to no opioid receipt. Female versus male gender was associated with a lower proportion of QHI achieved (62.32% vs 69.33%; adjusted difference = −7.01%; 95% CI −11.20%, −2.83%). There was no difference by HIV status.

Conclusions

Patients losing access to opioids may receive less recommended preventive health care. Maintaining engagement in preventive and other healthcare should be a central component of opioid stewardship.